Things you’ll learn:
We'll cover safety and risk mitigation, before and during the clinical trial along with:
- upcoming guidelines on preclinical safety assessment.
- how to use human-based in-vitro studies to improve the safety in clinical trials.
- MABEL, NOAEL and receptor binding.
- time between dosing within and between cohorts.